Global Health

Global Health AAQS

The The AAQS of Global Health (MEDANTA.NS) as of Nov 7, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Global Health has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Global Health in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Global Health AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2019
4.00 INR
Jan 1, 2020
4.00 INR
Jan 1, 2021
4.00 INR
Jan 1, 2022
4.00 INR
Jan 1, 2023
4.00 INR
Jan 1, 2024
4.00 INR
Jan 1, 2025
4.00 INR
Jan 1, 2026
4.00 INR
The Global Health AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Global Health Stock analysis

What does Global Health do? Global Health Ltd. provides healthcare, pathology, and medical services through its Medanta brand, operating five hospitals in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow, alongside six Mediclinic diagnostic laboratories. The company generates revenue by delivering treatments for conditions such as coronary artery disease, head and neck cancer, acute myeloid leukemia, and chronic kidney disease, alongside specialized services in cardiac surgery, nephrology, urology, and interventional cardiology. Its offerings include medicine delivery, lab tests & diagnostics, homecare, and telemedicine, targeting patients seeking advanced medical care across multiple specialties. Medanta serves urban and semi-urban segments in India, focusing on high-demand treatments and comprehensive healthcare solutions. The company monetizes through direct patient services at its hospitals and diagnostic centers, with revenue derived from procedures, consultations, and diagnostic tests. Treatments for chronic conditions like diabetes, hypertension, and bronchial asthma, as well as acute cases such as cerebral stroke and sepsis, form a significant portion of its service portfolio. Patients utilize Medanta’s telemedicine and homecare services for convenience, while its diagnostic labs provide lab tests & diagnostics to both in-person and remote clients. Revenue streams are driven by high-volume treatments and specialized medical expertise across its network of facilities. Medanta’s service mix includes cardiology, oncology, neurology, and orthopedics, with a focus on conditions like Parkinson’s disease, prostate cancer, and rheumatoid arthritis. The company’s revenue model relies on comprehensive care packages, including hospital stays, outpatient visits, and follow-up services. Its facilities in Delhi, Gurugram, and other cities cater to both private and government-affiliated patients, though the business description does not specify government contracts. The company’s diagnostic laboratories and telemedicine services expand its reach, enabling revenue from multiple touchpoints within the healthcare ecosystem. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

The AAQS of Global Health is 4 in 2026.

On Eulerpool you can find the complete historical development of The AAQS Global Health since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Global Health

All Key Metrics — Global Health